Moderna Reaches Analyst Target Price
21/5 13:02
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $136.15, changing hands for $141.04/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat...